GlassScriptPhysician profile
Dwight D Hood
NPI 1124037171
$2,172.46
in general payments reported to CMS, 2019-2025
22 companies · $289 in 2025
The $289 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $175 · 2021: $206 · 2022: $325 · 2023: $682 · 2024: $274 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,244.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $433.60 | 2020-2025 | Mounjaro, Jardiance, Emgality |
| Abbvie INC. | $407.01 | 2021-2025 | |
| Glaxosmithkline, LLC. | $205.80 | 2021-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $156.01 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $143.25 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $124.52 | 2023-2025 | Breztri, Airsupra |
| Astellas Pharma US INC | $92.35 | 2019-2024 | Veozah |
| Exact Sciences Corporation | $85.84 | 2023-2024 | Cologuard Collection Kit |
| Paratek Pharmaceuticals, INC. | $85.20 | 2024-2025 | Nuzyra, Xhance |
| Biohaven Pharmaceutical Holding Company LTD. | $80.78 | 2022 | |
| Novo Nordisk INC | $56.64 | 2020-2024 | Rybelsus, Ozempic |
| Abbott Laboratories | $50.07 | 2022-2025 | Freestyle Libre 3 |
| Myriad Women'S Health, INC. | $45.04 | 2023 | Myrisk |
| Dexcom, INC. | $39.25 | 2023-2025 | Dexcom G6 Transmitter |
| Genentech USA, INC. | $39.22 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $22.02 | 2021 | |
| Inspire Medical Systems, INC. | $21.97 | 2025 | Inspire |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.72 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.07 | 2019 | |
| Mylan Specialty L.P. | $17.00 | 2019 | |
| Janssen Pharmaceuticals, INC | $15.86 | 2019 | |
| Si-Bone, INC. | $15.24 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwight Hood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.